Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Translational research and treating resistance

Radiotherapy at Tata Memorial Hospital

Treatment choices in head and neck cancer

Boosted radiotherapy fractions to treat rectal cancer

Mechanisms of resistance in triple negative breast cancer

Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines

Treatment options for newly diagnosed multiple myeloma and management of bone disease: Roundtable at IMW 2017

Ongoing transplant phase III trials for myeloma

Teaming up with competitors in HARMONY

Stem cell transplant for geriatric ALL

Targets for therapy in ETP-ALL